Filtered By:
Condition: Heart Attack
Management: Electronic Health Records (EHR)

This page shows you your search results in order of date. This is page number 2.

Order by Relevance | Date

Total 103 results found since Jan 2013.

Rates of  Preeclampsia and Post-preeclamptic Cardiovascular Disease Among US Military Servicewomen: A Retrospective Case-cohort Study
CONCLUSION: In this study, we report overall higher incidence of PE in military women than what is published for civilian women in all races and across all services. Importantly, we do not find significantly higher numbers of PE and post-PE CVD for African American, compared to White women in the military. Our study is not designed to address differences between military and civilian PE epidemiology, but these results deserve further exploration. This study shines light on a health risk unique to women, which we found to be more prevalent in the US Military than published civilian population. Further study to determine the...
Source: Military Medicine - August 4, 2023 Category: International Medicine & Public Health Authors: Thornton S Mu Amelia Duran-Stanton Emily A Stone Lee Ann Zarzabal Andrea Loewendorf Source Type: research

Use of neuromuscular blockade for neck dissection and association with iatrogenic nerve injury
CONCLUSIONS: In this study, use of neuromuscular blockade intraoperatively during neck dissection was not associated with increased rates of iatrogenic cranial nerve injury. While this investigation provides early support for safe use of neuromuscular blockade during neck dissection, future investigation with greater power remains necessary.PMID:37507689 | DOI:10.1186/s12871-023-02217-7
Source: Atherosclerosis - July 28, 2023 Category: Cardiology Authors: Joshua D Smith Graciela Mentz Aleda M Leis Yuan Yuan Chaz L Stucken Steven B Chinn Keith A Casper Kelly M Malloy Andrew G Shuman Scott A McLean Andrew J Rosko Mark E P Prince Kevin K Tremper Matthew E Spector Samuel A Schechtman Source Type: research

Associations of Serum 25(OH)D with Risk of Recurrent Cardiovascular Events in Individuals with Coronary Heart Disease
This study aimed to investigate the associations of serum 25-hydroxyvitamin D [25(OH)D] concentration and the vitamin D receptor (VDR) polymorphisms with the risk of recurrent cardiovascular events in individuals with established CHD.METHODS: A total of 22,571 participants with CHD were included from the UK Biobank. Recurrent cardiovascular events, including myocardial infarction (MI), heart failure (HF), stroke, and CVD mortality, were identified from electronic health records. Cox proportional hazard models were used to calculate hazard ratios (HRs) and 95% confidence intervals (CIs).RESULTS: The median (interquartile ra...
Source: The Journal of Clinical Endocrinology and Metabolism - June 6, 2023 Category: Endocrinology Authors: Xiaoyu Lin Xue Chen Sen Liu Yulei Deng Yuexuan Wang Qi Lu Rui Li Yunjing Ou Qingying Tian Yunfei Liao Guanglin Cui Kun Yang An Pan Gang Liu Source Type: research

Perioperative adverse cardiac events and mortality after non-cardiac surgery: a multicenter study
CONCLUSIONS: A nationwide multicenter study showed that PACE was significantly associated with increased one-year mortality. This association was stronger in high-risk surgery, older, male, and chronic kidney disease subgroups. Further studies to improve mortality associated with PACE are needed.PMID:37169362 | DOI:10.4097/kja.23043
Source: Korean Journal of Anesthesiology - May 11, 2023 Category: Anesthesiology Authors: Byungjin Choi Ah Ran Oh Jungchan Park Jong-Hwan Lee Kwangmo Yang Dong Yun Lee Sang Youl Rhee Sang-Soo Kang Seung Do Lee Sun Hack Lee Chang Won Jeong Bumhee Park Soobeen Seol Rae Woong Park Seunghwa Lee Source Type: research

Rivaroxaban for Prevention of Thrombotic Events, Hospitalization, and Death in Outpatients With COVID-19: A Randomized Clinical Trial
CONCLUSIONS: The study was terminated prematurely after enrollment of 32% of planned accrual because of recruitment challenges and lower-than-expected event rate. Rivaroxaban prescribed for 35 days in nonhospitalized patients with symptomatic COVID-19 at risk for thrombosis did not appear to reduce a composite end point of venous and arterial thrombotic events, hospitalization, and death.REGISTRATION: URL: https://www.CLINICALTRIALS: gov; Unique identifier: NCT04508023.PMID:37154020 | DOI:10.1161/CIRCULATIONAHA.123.063901
Source: Circulation - May 8, 2023 Category: Cardiology Authors: Gregory Piazza Alex C Spyropoulos Judith Hsia Mark Goldin William J Towner Alan S Go Todd M Bull Stephen Weng Concetta Lipardi Elliot S Barnathan Marc P Bonaca PREVENT-HD Investigators Source Type: research

Clinical impact of the infrapatellar location in symptomatic peripheral arterial disease patients
CONCLUSION: Infrapatellar disease was anindependent factor for increased hospitalization of CLTI, major and minor amputations events, compared to suprapatellardisease in symptomatic revascularized PAD patients.PMID:36480817 | DOI:10.24875/ACM.22000161
Source: Archivos de Cardiologia de Mexico - December 8, 2022 Category: Cardiology Authors: Juan G Chiabrando Fernando D Garagoli Maria M Abraham Foscolo Giuliana Corna Maria de Los Milagros Fleitas Juan Valle-Raleigh Horacio A Medina de Chazal Daniel H Berrocal Jose M Rabellino Ignacio M Bluro Source Type: research